A Study To Evaluate The Safety And Therapeutic Equivalence of Tazarotene Foam 0.1% in Subjects With Acne Vulgaris
Clinical trial NCT02267746 · COMPLETED
Trial details
- NCT number
- NCT02267746
- Sponsor
- Actavis Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2014-06-01
- Primary completion
- 2014-09-01
- Enrollment
- 893
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.